American International Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-46,060
| Closed | -$869K | – | 3107 |
|
|
2019
Q3 | $869K | Sell |
46,060
-322
| -0.7% | -$3.68K | ﹤0.01% | 1368 |
|
|
2019
Q2 | $546K | Buy |
46,382
+9,230
| +25% | +$112K | ﹤0.01% | 1656 |
|
|
2019
Q1 | $507K | Sell |
37,152
-1,204
| -3% | -$15.6K | ﹤0.01% | 1699 |
|
|
2018
Q4 | $393K | Sell |
38,356
-295
| -0.8% | -$3.78K | ﹤0.01% | 1810 |
|
|
2018
Q3 | $644K | Buy |
38,651
+696
| +2% | +$12.6K | ﹤0.01% | 1726 |
|
|
2018
Q2 | $600K | Sell |
37,955
-2,570
| -6% | -$39.1K | ﹤0.01% | 1710 |
|
|
2018
Q1 | $515K | Sell |
40,525
-2,179
| -5% | -$31.5K | ﹤0.01% | 1704 |
|
|
2017
Q4 | $489K | Buy |
42,704
+644
| +2% | +$7.19K | ﹤0.01% | 1811 |
|
|
2017
Q3 | $515K | Buy |
42,060
+12,784
| +44% | +$133K | ﹤0.01% | 1744 |
|
|
2017
Q2 | $335K | Buy |
29,276
+427
| +1% | +$7.89K | ﹤0.01% | 1966 |
|
|
2017
Q1 | $600K | Buy |
28,849
+1,910
| +7% | +$42.3K | ﹤0.01% | 1482 |
|
|
2016
Q4 | $560K | Sell |
26,939
-70
| -0.3% | -$1.82K | ﹤0.01% | 1569 |
|
|
2016
Q3 | $885K | Buy |
27,009
+41
| +0.2% | +$1.25K | ﹤0.01% | 1283 |
|
|
2016
Q2 | $673K | Buy |
26,968
+13,394
| +99% | +$362K | ﹤0.01% | 1419 |
|
|
2016
Q1 | $332K | Buy |
13,574
+1,481
| +12% | +$34.3K | ﹤0.01% | 2326 |
|
|
2015
Q4 | $399K | Sell |
12,093
-21
| -0.2% | -$710 | ﹤0.01% | 2215 |
|
|
2015
Q3 | $397K | Buy |
12,114
+14
| +0.1% | +$595 | ﹤0.01% | 2218 |
|
|
2015
Q2 | $641K | Buy |
12,100
+7,069
| +141% | +$257K | ﹤0.01% | 1959 |
|
|
2015
Q1 | $145K | Hold |
5,031
| – | – | ﹤0.01% | 3249 |
|
|
2014
Q4 | $146K | Sell |
5,031
-198
| -4% | -$3.55K | ﹤0.01% | 3227 |
|
|
2014
Q3 | $66.3K | Sell |
5,229
-4
| -0.1% | -$60 | ﹤0.01% | 3848 |
|
|
2014
Q2 | $105K | Buy |
+5,233
| New | +$73.7K | ﹤0.01% | 3541 |
|
American International Group's ALDR Position: Q4 2019 in Review
American International Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 46,060 shares — an estimated $869K sold.
American International Group first reported a position in ALDR in Q2 2014 and held it in 22 quarters. The position peaked at $885K in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- American International Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- American International Group sold 46,060 Alder Biopharmaceuticals shares in Q4 2019, an estimated $869K.
- American International Group first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 22 quarters.
- American International Group's Alder Biopharmaceuticals position peaked at $885K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on American International Group's 13F filing for Q4 2019, filed 5 Feb 2020.